T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETOR
951
eToro Group
ETOR
$2.05B
| $40.3M | ﹤0.01% |
1,021,180
+396,478
| +63% | +$14.9M |
|
952
Commault Systems
CVLT
$6.14B
| $40.2M | ﹤0.01% |
283,798
+59,590
| +27% | +$6.4M |
|
|
SGI
953
Somnigroup International
SGI
$13.1B
| $40.2M | ﹤0.01% |
512,954
-209,970
| -29% | -$15.4M |
|
|
ABVX
954
Abivax
ABVX
$8.45B
| $40M | ﹤0.01% |
300,365
-391,305
| -57% | -$44.3M |
|
955
PPG Industries
PPG
$23.8B
| $39.7M | ﹤0.01% |
327,643
+8,642
| +3% | +$962K |
|
|
PENG
956
Penguin Solutions Inc
PENG
$2.82B
| $39.6M | ﹤0.01% |
521,248
+457,140
| +713% | +$20.8M |
|
|
PPL
957
PPL Corp
PPL
$24.2B
| $39.6M | ﹤0.01% |
1,089,586
+20,405
| +2% | +$754K |
|
958
NewAmsterdam Pharma
NAMS
$2.82B
| $39.6M | ﹤0.01% |
+1,167,357
| New | +$38.5M |
|
|
FPS
959
Forgent Power Solutions
FPS
$10B
| $39.4M | ﹤0.01% |
+705,966
| New | +$32.2M |
|
960
Indivior Pharmaceuticals
INDV
$4.35B
| $39.2M | ﹤0.01% |
955,110
+816,160
| +587% | +$29.6M |
|
961
GFL Environmental
GFL
$18.1B
| $39.1M | ﹤0.01% |
1,061,598
+924,309
| +673% | +$34.9M |
|
962
Eversource Energy
ES
$23.8B
| $39M | ﹤0.01% |
539,023
+7,034
| +1% | +$487K |
|
963
Copart
CPRT
$25.2B
| $38.9M | ﹤0.01% |
1,378,276
+12,277
| +0.9% | +$396K |
|
964
On Holding
ONON
$10B
| $38.5M | ﹤0.01% |
1,086,089
-749,717
| -41% | -$27.4M |
|
965
Regions Financial
RF
$23.2B
| $38.4M | ﹤0.01% |
1,271,689
-75,803
| -6% | -$2.13M |
|
966
Tyler Technologies
TYL
$13.3B
| $38.3M | ﹤0.01% |
130,870
-2,052
| -2% | -$649K |
|
967
Agilysys
AGYS
$2.74B
| $38M | ﹤0.01% |
363,687
+13,281
| +4% | +$1.03M |
|
968
Xencor
XNCR
$1.9B
| $37.9M | ﹤0.01% |
2,356,409
+795,989
| +51% | +$9.94M |
|
969
Immunome
IMNM
$2.46B
| $37.6M | ﹤0.01% |
1,773,229
-1,085,634
| -38% | -$23.2M |
|
970
IES Holdings
IESC
$12.8B
| $37.5M | ﹤0.01% |
102,220
-22,252
| -18% | -$7.18M |
|
971
Hershey
HSY
$33B
| $37.5M | ﹤0.01% |
213,479
+3,265
| +2% | +$616K |
|
972
Garrett Motion
GTX
$4.82B
| $37.3M | ﹤0.01% |
1,028,518
+901,995
| +713% | +$25.1M |
|
973
First Solar
FSLR
$18.6B
| $37.2M | ﹤0.01% |
157,649
-4,109
| -3% | -$963K |
|
974
Coca-Cola Europacific Partners
CCEP
$45.3B
| $36.4M | ﹤0.01% |
363,645
+31,956
| +10% | +$3.05M |
|
|
GENB
975
Generate Biomedicines
GENB
$1.91B
| $36.4M | ﹤0.01% |
2,156,627
+46,994
| +2% | +$640K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.